Anne‐Catrin Uhlemann
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria 31
- Infectious Diseases top 0.5%
- Antimicrobial Resistance in Staphylococcus 32
- Clostridium difficile and Clostridium perfringens research 18
- Biological Psychiatry top 1%
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 30
-
- Gut microbiota and health 25
- Bacterial biofilms and quorum sensing 15
-
- Malaria Research and Control 20
-
- Antibiotics Pharmacokinetics and Efficacy 10
- Co-authors
- Sanjeev KrishnaAngela Gomez‐SimmondsMedini K. AnnavajhalaFranklin D. LowyRichard K. HaynesFrançois NostenJ. John MannJeffrey M. Miller
- Journals
- Nature (2 papers)Proceedings of the National Academy of Sciences (1 paper)The Lancet (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Anne‐Catrin Uhlemann
154 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Molecular Medicine 1.2k
- Applied Microbiology and Biotechnology 323
- Infectious Diseases 2.3k
- Biological Psychiatry 297
- Clinical Biochemistry 715
Countries citing papers authored by Anne‐Catrin Uhlemann
This map shows the geographic impact of Anne‐Catrin Uhlemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Catrin Uhlemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Catrin Uhlemann more than expected).
Fields of papers citing papers by Anne‐Catrin Uhlemann
This network shows the impact of papers produced by Anne‐Catrin Uhlemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Catrin Uhlemann. The network helps show where Anne‐Catrin Uhlemann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anne‐Catrin Uhlemann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 1 | |
| 7 | Multiple pathways for SARS-CoV-2 resistance to nirmatrelvirbreakdown → | 2022 | 260 |
| 8 | 2021 | 36 | |
| 9 | 2021 | 51 | |
| 10 | 2021 | 103 | |
| 11 | 2021 | 3 | |
| 12 | 2021 | 94 | |
| 13 | 2021 | 80 | |
| 14 | 2020 | 167 | |
| 15 | 2020 | 51 | |
| 16 | 2019 | 35 | |
| 17 | 2018 | 10 | |
| 18 | 2017 | 71 | |
| 19 | 2016 | 28 | |
| 20 | 2014 | 118 |
About Anne‐Catrin Uhlemann
Anne‐Catrin Uhlemann is a scholar working on Molecular Medicine, Clinical Biochemistry and Applied Microbiology and Biotechnology, having authored 163 papers that have together received 7.5k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (32 papers), Antibiotic Resistance in Bacteria (31 papers), Bacterial Identification and Susceptibility Testing (30 papers), Gut microbiota and health (25 papers), Malaria Research and Control (20 papers), Clostridium difficile and Clostridium perfringens research (18 papers), Bacterial biofilms and quorum sensing (15 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). The work is most often cited by research in Molecular Medicine (1.2k citations), Applied Microbiology and Biotechnology (323 citations) and Infectious Diseases (2.3k citations). Anne‐Catrin Uhlemann has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Sanjeev Krishna, Angela Gomez‐Simmonds, Medini K. Annavajhala, Franklin D. Lowy, Richard K. Haynes, François Nosten, J. John Mann, Jeffrey M. Miller, Stephanie Cheung and M. Elizabeth Sublette. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.